Conducting a clinical trial on amnion lyophilized product in improving complications after laser

Conducting a clinical trial on amnion lyophilized allograft product in improving complications after fractional CO2 laser

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200127046282N45

Enrollment

Registered

2024-06-19

Start date

2024-06-20

Completion date

Unknown

Last updated

2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin aging. Atrophic disorder of skin

Interventions

Intervention 1: Intervention group: The patient will receive Fractional CO2 laser in three sessions with an interval of one month, and after the laser, 2 cc of the product will be sprayed on the face.

Eligibility

Sex/Gender

All

Age

30 Years to 60 Years

Inclusion criteria

Inclusion criteria: Age between 30-60 Having middle wrinkles in face region

Exclusion criteria

Exclusion criteria: Pregnancy and breastfeeding History of cancer Patients with a new history of gel and Botox injections People with Mental Disorders Active infection in the face

Design outcomes

Primary

Measure	Time frame
The amount of wrinkles. Timepoint: Before treatment and one month after the last session. Method of measurement: Visio face.	—

Secondary

Measure	Time frame
Side effects. Timepoint: in each session. Method of measurement: Questionnaire and visit.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSona Zare

Skin and Stem Cell Research Center of Tehran University of Medical Sciences

sonazarebio@gmail.com+98 21 2665 7438

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026